Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis
Open Access
- 27 June 2006
- journal article
- research article
- Published by Elsevier
- Vol. 1763 (9) , 958-968
- https://doi.org/10.1016/j.bbamcr.2006.06.006
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patientsCancer Cell, 2004
- Distinctive regulation and function of PI 3K/Akt and MAPKs in doxorubicin‐induced apoptosis of human lung adenocarcinoma cellsJournal of Cellular Biochemistry, 2004
- Identification of a novel antiapoptotic protein that antagonizes ASK1 and CAD activitiesThe Journal of cell biology, 2003
- AKT2 Inhibition of Cisplatin-induced JNK/p38 and Bax Activation by Phosphorylation of ASK1Journal of Biological Chemistry, 2003
- HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cellsOncogene, 2003
- The Specificity of Extracellular Signal-regulated Kinase 2 Dephosphorylation by Protein PhosphatasesJournal of Biological Chemistry, 2002
- MEK6 Regulates Human Involucrin Gene Expression via a p38α- and p38δ-dependent MechanismPublished by Elsevier ,2001
- p38 Mitogen-activated Protein Kinase Pathway Protects Adult Rat Ventricular Myocytes against β-Adrenergic Receptor-stimulated ApoptosisPublished by Elsevier ,2000
- Suppression by Metallothionein of Doxorubicin-induced Cardiomyocyte Apoptosis through Inhibition of p38 Mitogen-activated Protein KinasesPublished by Elsevier ,2000
- Induction of Apoptosis by SB202190 through Inhibition of p38β Mitogen-activated Protein KinaseJournal of Biological Chemistry, 1998